PHARMACY BENEFIT MANAGERS – Amends and adds to existing law to establish provisions regarding dispensing fees and to establish duties and restrictions pertaining to pharmacy benefit managers and third-party payers.
Summary
S1367 amends Idaho law governing pharmacy benefit managers (PBMs) and prescription drug reimbursement. The bill sets a minimum professional dispensing fee of $12.35 per prescription that PBMs must pay to pharmacies, and it directs that pharmacy reimbursement for prescription drugs be based on the National Average Drug Acquisition Cost (NADAC). It also establishes a methodology for adjusting dispensing fees in the future and assigns oversight and implementation responsibilities to the Idaho Department of Insurance.
In practical terms, the bill would change how PBMs and other third-party payers reimburse pharmacies for dispensing prescription drugs in Idaho. By tying reimbursement to NADAC and requiring a minimum dispensing fee, the measure is intended to standardize payment practices and support pharmacy operations, particularly independent pharmacies that argue current reimbursement levels are too low. The Department of Insurance would administer the new requirements under its existing authority, with no expected additional administrative staffing impact.
The general sentiment reflected in the bill materials is supportive of the measure’s goals of improving pharmacy reimbursement and regulating PBM practices. The statement of purpose presents the bill as a targeted reform to pharmacy payment rules, and there is no recorded committee testimony or vote history in the provided materials showing organized opposition or amendment debate. The fiscal note, however, indicates a likely cost increase for state-funded health plans, including an estimated $3.7 million annual increase for the state employee health insurance plan.
The main point of contention is the cost impact on insurers and public health benefit plans versus the benefit to pharmacies. Supporters appear to favor stronger reimbursement standards and greater oversight of PBMs, while the fiscal note highlights that those changes could raise premiums or plan costs for the state and other payers. The bill therefore sits at the intersection of pharmacy access, PBM regulation, and state health care spending.
Impact
The bill would amend Section 41-349, Idaho Code, and add new requirements for pharmacy benefit managers and third-party payers regarding pharmacy reimbursement. It would require a minimum dispensing fee of $12.35 per prescription, base drug reimbursement on NADAC, and give the Idaho Department of Insurance authority to oversee implementation. The measure could increase costs for state-funded health plans, including the state employee health insurance program, while potentially improving pharmacy reimbursement rates and financial stability for pharmacies.
Sentiment
The available materials suggest a generally favorable sentiment toward the bill’s policy objectives, especially among its sponsors and proponents, who frame it as a needed reform to PBM reimbursement practices. No committee transcript or vote record is provided showing formal opposition or divided debate. The fiscal note, however, signals concern about higher costs to state health plans, which is likely the primary source of caution around the bill.
Contention
The central contention is whether the bill’s higher reimbursement requirements are justified by the benefits to pharmacies and prescription access. Supporters likely view the minimum dispensing fee and NADAC-based reimbursement as necessary to address underpayment by PBMs, while opponents or cost-conscious stakeholders may object to the estimated increase in state and plan spending. The Idaho Department of Insurance is not expected to face added administrative burden, so the dispute is mainly about financial impact on payers versus reimbursement adequacy for pharmacies.